Question 1

What are the potential side effects of the JS016 treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects clinical trial (NCT04441918). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects clinical trial (NCT04441918). Contact the study team or your healthcare provider for specific answers.

Question 3

What should I do if I experience any adverse reactions?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects clinical trial (NCT04441918). Contact the study team or your healthcare provider for specific answers.

Question 4

How does this treatment compare to other COVID-19 treatments available?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects clinical trial (NCT04441918). Contact the study team or your healthcare provider for specific answers.

Question 5

What is the timeline for the study and how often will I need to visit?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects clinical trial (NCT04441918). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects clinical trial (NCT04441918). Contact the study team or your healthcare provider for specific answers.

What this study is about